Cost-Effectiveness of the CNIC-Polypill Strategy Compared With Separate Monocomponents in Secondary Prevention of Cardiovascular and Cerebrovascular Disease in Portugal: The MERCURY Study

Background: Cardiovascular (CV) diseases remain a leading and costly cause of death globally. Patients with previous CV events are at high risk of recurrence. Secondary prevention therapies improve CV risk factor control and reduce disease costs. Objectives: To assess the cost-effectiveness of a CV...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguiar, Carlos, Araujo, Francisco, Rubio-Mercade, Gabriel, Carcedo, David, Paz, Silvia, Castellano, Jose María, Fuster, Valentín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Columbia Data Analytics, LLC 2022
Materias:
Cardiovascular Conditions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687308/
https://www.ncbi.nlm.nih.gov/pubmed/36475278
http://dx.doi.org/10.36469/001c.39768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687308/
https://www.ncbi.nlm.nih.gov/pubmed/36475278
http://dx.doi.org/10.36469/001c.39768

Ejemplares similares